Reuters logo
BRIEF-ICU Medical updates on Hospira Infusion Systems deal
January 5, 2017 / 9:31 PM / 9 months ago

BRIEF-ICU Medical updates on Hospira Infusion Systems deal

Jan 6 (Reuters) - Icu Medical Inc

* ICU medical, inc. Provides update on Hospira Infusion Systems Transaction

* ICU medical inc - U.S. and other required antitrust clearances for transaction received

* ICU Medical Inc - company expects deal to close in february 2017

* ICU Medical Inc - co, pfizer have modified terms of definitive agreement entered into on october 6, 2016

* ICU Medical Inc - under terms of modified agreement, aggregate purchase price will be adjusted to be no more than $900 million

* ICU Medical - pfizer to receive $400 million in equity in form of 3.2 million newly issued ICU Medical shares and $275 million in cash

* ICU Medical Inc says expects to have approximately $150 million net cash and $225 million total cash at close of transaction

* ICU Medical - Pfizer may be entitled up to additional $225 million based on achievement of performance targets for combined co through december 31, 2019 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below